ProPhase Labs, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity - Narrative (Details)

Stockholders’ Equity - Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands													3 Months Ended		6 Months Ended		12 Months Ended
	Apr. 07, 2023	Apr. 06, 2023	Apr. 04, 2023	Mar. 15, 2023	Jan. 26, 2023	Jan. 12, 2023	Jun. 03, 2022	May 09, 2022	Feb. 14, 2022	Sep. 08, 2021	May 20, 2021	Apr. 12, 2018	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Jun. 16, 2023	Jan. 27, 2023	Dec. 15, 2022	May 19, 2022
Equity, Class of Treasury Stock [Line Items]
Common stock, authorized (in shares)													50,000,000		50,000,000		50,000,000
Common stock, par value (in dollars per share)													$ 0.0005		$ 0.0005		$ 0.0005			$ 0.0005
Preferred stock, authorized (in shares)													1,000,000		1,000,000		1,000,000
Preferred stock, par value (in dollars per share)													$ 0.0005		$ 0.0005		$ 0.0005
Preferred stock, issued (in shares)													0		0		0
Dividends declared															$ 0
Cash dividend declared (in dollars per share)								$ 0.30	$ 0.30
Payments of ordinary dividends								$ 4,700	$ 4,600
Stock repurchase, authorized				$ 6,000						$ 6,000
Stock repurchase, period (in months)				6 months						6 months
Stock options granted (in shares)													120,000		1,125,000
Options, value															$ 4,100
Return of shares (in shares)															744,369
Cash payment for repurchase															$ 5,400
Treasury stock repurchased (in shares)															603,881
Exercise price (in price per share)						$ 10.00
Award vesting period (in years)						5 years
Estimated fair value of options at date of grant						$ 300
Warrants term (in years)						1 year													5 years
Closing stock price (in dollars per share)													$ 7.26		$ 7.26
Share-based compensation expense													$ 1,100	$ 500	$ 2,000	$ 1,000
Share-based compensation expense, remaining															$ 7,800
Weighted average remaining contractual life, outstanding shares (in years)															4 years 9 months 18 days
Prepaid expenses and other current assets													$ 3,667		$ 3,667		$ 2,366
2023 Notes Warrants
Equity, Class of Treasury Stock [Line Items]
Warrants (in shares)					76,000														76,000
Exercise price (in price per share)					$ 9.00
Expected volatility rate					81.50%
Risk free interest rate					3.62%
Warrants term (in years)					5 years
Warrant, fair value					$ 380
Stock Options
Equity, Class of Treasury Stock [Line Items]
Expected volatility rate															80.00%
Risk free interest rate															3.70%
Warrant life (in years)															4 years 8 months 12 days
Common Stock
Equity, Class of Treasury Stock [Line Items]
Shares repurchased (in shares)													6,012		69,628	200,000
Stock options exercised (in shares)														236,927	603,881	236,927
Warrant
Equity, Class of Treasury Stock [Line Items]
Warrants (in shares)		250,000				50,000
Exercise price (in price per share)		$ 9.00
Expected volatility rate		80.40%				80.90%
Risk free interest rate		3.59%				3.53%
Warrant life (in years)		5 years				5 years
Warrants term (in years)		5 years
Weighted average remaining contractual life, outstanding shares (in years)															1 year 8 months 12 days		1 year 10 months 24 days
Warrant, fair value		$ 1,400
Prepaid expenses and other current assets													$ 1,300		$ 1,300
2022 Directors Plan
Equity, Class of Treasury Stock [Line Items]
Shares reserved for future issuance (in shares)													210,000		210,000						300,000
Amended 2010 Directors' Plan
Equity, Class of Treasury Stock [Line Items]
Number of shares authorized (in shares)											775,000
Amended 2010 Plan
Equity, Class of Treasury Stock [Line Items]
Shares issued (in shares)											4,900,000
Stock options granted (in shares)																0
2018 Stock Incentive Plan
Equity, Class of Treasury Stock [Line Items]
Stock options exercised (in shares)															1,100,000	0
2018 Stock Incentive Plan \| CEO Options
Equity, Class of Treasury Stock [Line Items]
Exercise price (in dollars per share)							$ 0.60
Amended 2022 Directors' Plan
Equity, Class of Treasury Stock [Line Items]
Increase in shares reserved for future issuance (in shares)																		150,000
2022 Plan
Equity, Class of Treasury Stock [Line Items]
Shares reserved for future issuance (in shares)													703,285		703,285
Increase in shares reserved for future issuance (in shares)																					1,000,000
Common stock issued (in shares)													1,005,000		1,005,000
2022 Plan \| Stock Options
Equity, Class of Treasury Stock [Line Items]
Stock options granted (in shares)	250,000
Exercise price (in dollars per share)			$ 9.00
Exercise price (in price per share)	$ 10.00
Award vesting period (in years)	3 years		5 years
Estimated fair value at date of grant	$ 99		$ 2,700
2022 Plan \| Stock Options \| Vesting Period One
Equity, Class of Treasury Stock [Line Items]
Options vesting percentage	25.00%
2022 Plan \| Stock Options \| Vesting Period Two
Equity, Class of Treasury Stock [Line Items]
Options vesting percentage	75.00%
Amended 2022 Plan
Equity, Class of Treasury Stock [Line Items]
Increase in shares reserved for future issuance (in shares)																		700,000
Chief Executive Officer \| 2018 Stock Incentive Plan
Equity, Class of Treasury Stock [Line Items]
Stock issued during period (in shares)												2,300,000
Stock options granted (in shares)												2,300,000
CEO and CFO \| 2022 Plan \| Stock Options
Equity, Class of Treasury Stock [Line Items]
Stock options granted (in shares)			550,000
Share Repurchase Program
Equity, Class of Treasury Stock [Line Items]
Shares repurchased (in shares)													69,628